HeartWare shares up as FDA safety review minimized
Mon, Apr 23 10:08 AM EDT
WASHINGTON (Reuters) - U.S. medical device reviewers said HeartWare International Inc's blood pump seemed to help people with severe heart failure but raised concerns about device-associated clotting rates and stroke.